+关注
我是你的好朋友
来自韭园的韭菜
IP属地:未知
21
关注
1
粉丝
0
主题
0
勋章
主贴
热门
我是你的好朋友
05-15
OKLO有点完犊子了,下跌的比较狠,这一次的扩股,到底是风险还是机遇?这对于当前股价来说,是个很坏很坏的消息。
@请叫我瞳哥:洗盘不用慌!暗藏拐点,二次拉升即将启动😮💨 5.14美股指数创新高,但小票集体分歧洗盘,最近持仓确实拿得很磨人,大家心态别崩!
$Oklo Inc.(OKLO)$
$NANO Inc(NNE)$
$Rigetti Computing(RGTI)$
4只持仓整体趋势全部守住,没有破位走坏,属于正常情绪回调蓄力🛡️ OKLO短期持续回踩,接下来重点观察2-3个交易日,能否站稳30日均线上方企稳反弹,站稳就是新一轮机会。 NNE盘后出炉重磅财报,整体大幅超预期!亏损明显收窄,基本面持续变好。 目前仍在研发商业化阶段,盘后小幅上涨4%,估值修复行情值得博弈。 现在就是拉升前最后洗盘,逻辑全部在线,耐心持股坐等反攻就行! 大家手里都拿了哪只?成本多少?评论区抱团一起等大涨🔥
我是你的好朋友
05-13
今天买入okll,成本价9.9
@请叫我瞳哥:📊5.13 盘前|通胀扰动震荡消化,航天军工企稳待突破✨ 【📰盘前资讯】 隔夜美股涨跌分化,道指小幅收涨,纳指、标普小幅回落,市场受超预期4月CPI数据扰动,通胀担忧小幅升温。美债收益率小幅上行,资金高低切换明显,高位科技股获利回吐,低位题材、财报催化小票承接强势。今日盘前期指小幅回暖,整体维持结构性震荡行情,无系统性风险,操作继续聚焦企稳突破+财报潜伏机会。 【🔥今日主线】 ✅ 航天国防航空:连续洗盘缩量企稳,板块承接扎实,短线突破窗口临近 ✅ 财报催化小票:业绩预期落地,低位潜伏标的迎来修复行情 ✅ 科技细分赛道:分歧震荡消化,回踩企稳低吸为主,不追高博弈 【💡操作思路】 坚守只做放量突破、缩量企稳优质标的原则,规避弱势阴跌个股。 震荡市严格控仓,持仓带好止损止盈,不扛单、不贪回撤。 优先布局形态修复完成、有财报/题材催化的低位标的,抓确定性短线行情。 【📈持仓策略】 ✅OKLO
$Oklo Inc.(OKLO)$
成本:69 昨日收盘价:73.6 浮盈:+6.7% 止损:上调至成本69 目标:100+ 现状:昨日深度洗盘但日内承接极强,属于典型诱空洗盘,多头趋势完全守住,筹码未松动,静待后续趋势拉升+情绪共振🚀 ✅Carmell Therapeutics(CRML) 成本:11.5 昨日收盘价:11.87 浮盈:+3.2% 止损:10.3 目标:15.5 / 18 现状:小幅震荡洗盘蓄力,下方均线支撑稳固,抛压持续衰竭,形态保持强势,随时开启反弹修复行情📊 ✅RGTI
$Rigetti Computing(RGTI)$
我是你的好朋友
05-12
完犊了吧?是不是不行了?
@万亿火箭兵
Hims & Hers Health Q1营收同比增长4%,但盈利未达预期出现亏损
我是你的好朋友
05-07
厉害的,今天选择清仓先!OKLO高于80属于风险区间了
抱歉,原内容已删除
我是你的好朋友
05-01
牛啊!你卖的这几个都不错,我只买了OKLO,强烈看好突破80的阻力位,目标价100.
@万亿火箭兵:🔥(5.1)美股盘后分析| 赛道为王,持仓全线爆发 📈一、市场反弹核心因素拆解 昨夜美股三大指数集体收涨,道指涨1.62%、标普500涨1.02%、纳指涨0.89%,纳指与标普再创历史新高✨,科技股形成分化,但大部分板块和个股明显反弹,核心驱动因素拆解: 1. 📊财报超预期,AI商业化兑现:谷歌财报爆冷,云AI收入增63%,股价涨近10%;亚马逊云业务增速创四年新高,带动市场情绪。科技股分化源于AI投入与回报的平衡,高变现、低资本压力标的受追捧。 2. 💹宏观面稳定,经济韧性强:美联储维持利率不变(3.50%-3.75%),符合预期;美国一季度GDP增2%,初请失业金人数低位,经济软着陆预期升温。 3. ⛽油价回落,通胀压力缓解:国际油价大跌超2%,消除通胀隐忧,成长股估值修复。 4. 💵月末资金回流,做多情绪集中释放:4月美股月度涨幅创近年最佳,最后交易日资金回流,推动普涨。 🚀二、持仓全线暴涨,浮动盈亏速览 持仓四只标的集体大涨,最弱涨幅超7%,OKLO开盘暴力拉升超11%,完美印证赛道逻辑✅: • 🚀
$Rocket Inc.(RKLB)$
(成本70-72):收盘价82.51,涨幅7.13% 浮动盈利:10.51-12.51美元/股,盈利率+14.6%-17.9% • ⚛️
$IONQ Inc.(IONQ)$
(成本44.8):收盘价45.15,涨幅7.2% 浮动盈利:0.35美元/股,盈利率+0.78% • 💥
$Oklo Inc.(OKLO)$
(成本70):开盘拉升
我是你的好朋友
04-30
$Oklo Inc.(OKLO)$
Oklo近期与英伟达及洛斯阿拉莫斯国家实验室达成三方合作,将利用AI数字孪生技术加速核燃料研发与验证,为“核能供电AI工厂”铺路。此外,汇丰银行以买入评级及96美元目标价首次覆盖该公司,Tigress Financial也给予买入评级及130美元目标价。 本人分批买入,目前满仓!
我是你的好朋友
2025-10-02
国庆节快乐!我没上车啊
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3483668508098944","uuid":"3483668508098944","gmtCreate":1617716446529,"gmtModify":1759403693197,"name":"我是你的好朋友","pinyin":"wsndhpywoshinidehaopengyou","introduction":"","introductionEn":null,"signature":"来自韭园的韭菜","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":21,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":3,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.16","exceedPercentage":"60.33%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":17,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":564510616967064,"gmtCreate":1778854366229,"gmtModify":1778855152456,"author":{"id":"3483668508098944","authorId":"3483668508098944","name":"我是你的好朋友","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483668508098944","authorIdStr":"3483668508098944"},"themes":[],"title":"","htmlText":"OKLO有点完犊子了,下跌的比较狠,这一次的扩股,到底是风险还是机遇?这对于当前股价来说,是个很坏很坏的消息。","listText":"OKLO有点完犊子了,下跌的比较狠,这一次的扩股,到底是风险还是机遇?这对于当前股价来说,是个很坏很坏的消息。","text":"OKLO有点完犊子了,下跌的比较狠,这一次的扩股,到底是风险还是机遇?这对于当前股价来说,是个很坏很坏的消息。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/564510616967064","repostId":"564275408799536","repostType":1,"repost":{"id":564275408799536,"gmtCreate":1778796941888,"gmtModify":1778796947209,"author":{"id":"4235754457199412","authorId":"4235754457199412","name":"请叫我瞳哥","avatar":"https://static.tigerbbs.com/913539812ee1ad056132f12f82e124b3","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4235754457199412","authorIdStr":"4235754457199412"},"themes":[],"title":"","htmlText":"洗盘不用慌!暗藏拐点,二次拉升即将启动😮💨 5.14美股指数创新高,但小票集体分歧洗盘,最近持仓确实拿得很磨人,大家心态别崩! <a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a> <a href=\"https://laohu8.com/S/NNE\">$NANO Inc(NNE)$ </a> <a href=\"https://laohu8.com/S/RGTI\">$Rigetti Computing(RGTI)$ </a> 4只持仓整体趋势全部守住,没有破位走坏,属于正常情绪回调蓄力🛡️ OKLO短期持续回踩,接下来重点观察2-3个交易日,能否站稳30日均线上方企稳反弹,站稳就是新一轮机会。 NNE盘后出炉重磅财报,整体大幅超预期!亏损明显收窄,基本面持续变好。 目前仍在研发商业化阶段,盘后小幅上涨4%,估值修复行情值得博弈。 现在就是拉升前最后洗盘,逻辑全部在线,耐心持股坐等反攻就行! 大家手里都拿了哪只?成本多少?评论区抱团一起等大涨🔥","listText":"洗盘不用慌!暗藏拐点,二次拉升即将启动😮💨 5.14美股指数创新高,但小票集体分歧洗盘,最近持仓确实拿得很磨人,大家心态别崩! <a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a> <a href=\"https://laohu8.com/S/NNE\">$NANO Inc(NNE)$ </a> <a href=\"https://laohu8.com/S/RGTI\">$Rigetti Computing(RGTI)$ </a> 4只持仓整体趋势全部守住,没有破位走坏,属于正常情绪回调蓄力🛡️ OKLO短期持续回踩,接下来重点观察2-3个交易日,能否站稳30日均线上方企稳反弹,站稳就是新一轮机会。 NNE盘后出炉重磅财报,整体大幅超预期!亏损明显收窄,基本面持续变好。 目前仍在研发商业化阶段,盘后小幅上涨4%,估值修复行情值得博弈。 现在就是拉升前最后洗盘,逻辑全部在线,耐心持股坐等反攻就行! 大家手里都拿了哪只?成本多少?评论区抱团一起等大涨🔥","text":"洗盘不用慌!暗藏拐点,二次拉升即将启动😮💨 5.14美股指数创新高,但小票集体分歧洗盘,最近持仓确实拿得很磨人,大家心态别崩! $Oklo Inc.(OKLO)$ $NANO Inc(NNE)$ $Rigetti Computing(RGTI)$ 4只持仓整体趋势全部守住,没有破位走坏,属于正常情绪回调蓄力🛡️ OKLO短期持续回踩,接下来重点观察2-3个交易日,能否站稳30日均线上方企稳反弹,站稳就是新一轮机会。 NNE盘后出炉重磅财报,整体大幅超预期!亏损明显收窄,基本面持续变好。 目前仍在研发商业化阶段,盘后小幅上涨4%,估值修复行情值得博弈。 现在就是拉升前最后洗盘,逻辑全部在线,耐心持股坐等反攻就行! 大家手里都拿了哪只?成本多少?评论区抱团一起等大涨🔥","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/564275408799536","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":563815670052104,"gmtCreate":1778684639492,"gmtModify":1778684642064,"author":{"id":"3483668508098944","authorId":"3483668508098944","name":"我是你的好朋友","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483668508098944","authorIdStr":"3483668508098944"},"themes":[],"title":"","htmlText":"今天买入okll,成本价9.9","listText":"今天买入okll,成本价9.9","text":"今天买入okll,成本价9.9","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/563815670052104","repostId":"563761791694632","repostType":1,"repost":{"id":563761791694632,"gmtCreate":1778671547058,"gmtModify":1778676249145,"author":{"id":"4235754457199412","authorId":"4235754457199412","name":"请叫我瞳哥","avatar":"https://static.tigerbbs.com/913539812ee1ad056132f12f82e124b3","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4235754457199412","authorIdStr":"4235754457199412"},"themes":[],"title":"","htmlText":"📊5.13 盘前|通胀扰动震荡消化,航天军工企稳待突破✨ 【📰盘前资讯】 隔夜美股涨跌分化,道指小幅收涨,纳指、标普小幅回落,市场受超预期4月CPI数据扰动,通胀担忧小幅升温。美债收益率小幅上行,资金高低切换明显,高位科技股获利回吐,低位题材、财报催化小票承接强势。今日盘前期指小幅回暖,整体维持结构性震荡行情,无系统性风险,操作继续聚焦企稳突破+财报潜伏机会。 【🔥今日主线】 ✅ 航天国防航空:连续洗盘缩量企稳,板块承接扎实,短线突破窗口临近 ✅ 财报催化小票:业绩预期落地,低位潜伏标的迎来修复行情 ✅ 科技细分赛道:分歧震荡消化,回踩企稳低吸为主,不追高博弈 【💡操作思路】 坚守只做放量突破、缩量企稳优质标的原则,规避弱势阴跌个股。 震荡市严格控仓,持仓带好止损止盈,不扛单、不贪回撤。 优先布局形态修复完成、有财报/题材催化的低位标的,抓确定性短线行情。 【📈持仓策略】 ✅OKLO<a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a><v-v data-views=\"1\"></v-v> 成本:69 昨日收盘价:73.6 浮盈:+6.7% 止损:上调至成本69 目标:100+ 现状:昨日深度洗盘但日内承接极强,属于典型诱空洗盘,多头趋势完全守住,筹码未松动,静待后续趋势拉升+情绪共振🚀 ✅Carmell Therapeutics(CRML) 成本:11.5 昨日收盘价:11.87 浮盈:+3.2% 止损:10.3 目标:15.5 / 18 现状:小幅震荡洗盘蓄力,下方均线支撑稳固,抛压持续衰竭,形态保持强势,随时开启反弹修复行情📊 ✅RGTI<a href=\"https://laohu8.com/S/RGTI\">$Rigetti Computing(RGTI)$ </a>","listText":"📊5.13 盘前|通胀扰动震荡消化,航天军工企稳待突破✨ 【📰盘前资讯】 隔夜美股涨跌分化,道指小幅收涨,纳指、标普小幅回落,市场受超预期4月CPI数据扰动,通胀担忧小幅升温。美债收益率小幅上行,资金高低切换明显,高位科技股获利回吐,低位题材、财报催化小票承接强势。今日盘前期指小幅回暖,整体维持结构性震荡行情,无系统性风险,操作继续聚焦企稳突破+财报潜伏机会。 【🔥今日主线】 ✅ 航天国防航空:连续洗盘缩量企稳,板块承接扎实,短线突破窗口临近 ✅ 财报催化小票:业绩预期落地,低位潜伏标的迎来修复行情 ✅ 科技细分赛道:分歧震荡消化,回踩企稳低吸为主,不追高博弈 【💡操作思路】 坚守只做放量突破、缩量企稳优质标的原则,规避弱势阴跌个股。 震荡市严格控仓,持仓带好止损止盈,不扛单、不贪回撤。 优先布局形态修复完成、有财报/题材催化的低位标的,抓确定性短线行情。 【📈持仓策略】 ✅OKLO<a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a><v-v data-views=\"1\"></v-v> 成本:69 昨日收盘价:73.6 浮盈:+6.7% 止损:上调至成本69 目标:100+ 现状:昨日深度洗盘但日内承接极强,属于典型诱空洗盘,多头趋势完全守住,筹码未松动,静待后续趋势拉升+情绪共振🚀 ✅Carmell Therapeutics(CRML) 成本:11.5 昨日收盘价:11.87 浮盈:+3.2% 止损:10.3 目标:15.5 / 18 现状:小幅震荡洗盘蓄力,下方均线支撑稳固,抛压持续衰竭,形态保持强势,随时开启反弹修复行情📊 ✅RGTI<a href=\"https://laohu8.com/S/RGTI\">$Rigetti Computing(RGTI)$ </a>","text":"📊5.13 盘前|通胀扰动震荡消化,航天军工企稳待突破✨ 【📰盘前资讯】 隔夜美股涨跌分化,道指小幅收涨,纳指、标普小幅回落,市场受超预期4月CPI数据扰动,通胀担忧小幅升温。美债收益率小幅上行,资金高低切换明显,高位科技股获利回吐,低位题材、财报催化小票承接强势。今日盘前期指小幅回暖,整体维持结构性震荡行情,无系统性风险,操作继续聚焦企稳突破+财报潜伏机会。 【🔥今日主线】 ✅ 航天国防航空:连续洗盘缩量企稳,板块承接扎实,短线突破窗口临近 ✅ 财报催化小票:业绩预期落地,低位潜伏标的迎来修复行情 ✅ 科技细分赛道:分歧震荡消化,回踩企稳低吸为主,不追高博弈 【💡操作思路】 坚守只做放量突破、缩量企稳优质标的原则,规避弱势阴跌个股。 震荡市严格控仓,持仓带好止损止盈,不扛单、不贪回撤。 优先布局形态修复完成、有财报/题材催化的低位标的,抓确定性短线行情。 【📈持仓策略】 ✅OKLO$Oklo Inc.(OKLO)$ 成本:69 昨日收盘价:73.6 浮盈:+6.7% 止损:上调至成本69 目标:100+ 现状:昨日深度洗盘但日内承接极强,属于典型诱空洗盘,多头趋势完全守住,筹码未松动,静待后续趋势拉升+情绪共振🚀 ✅Carmell Therapeutics(CRML) 成本:11.5 昨日收盘价:11.87 浮盈:+3.2% 止损:10.3 目标:15.5 / 18 现状:小幅震荡洗盘蓄力,下方均线支撑稳固,抛压持续衰竭,形态保持强势,随时开启反弹修复行情📊 ✅RGTI$Rigetti Computing(RGTI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/563761791694632","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":154,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":563247321208184,"gmtCreate":1778540112943,"gmtModify":1778540115720,"author":{"id":"3483668508098944","authorId":"3483668508098944","name":"我是你的好朋友","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483668508098944","authorIdStr":"3483668508098944"},"themes":[],"title":"","htmlText":"完犊了吧?是不是不行了?<a href=\"https://laohu8.com/U/4195019739358082\">@万亿火箭兵 </a>","listText":"完犊了吧?是不是不行了?<a href=\"https://laohu8.com/U/4195019739358082\">@万亿火箭兵 </a>","text":"完犊了吧?是不是不行了?@万亿火箭兵 ","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/563247321208184","repostId":"1194384043","repostType":2,"repost":{"id":"1194384043","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1778538229,"share":"https://www.laohu8.com/m/news/1194384043?lang=zh_CN&edition=full","pubTime":"2026-05-12 06:23","market":"us","language":"zh","title":"Hims & Hers Health Q1营收同比增长4%,但盈利未达预期出现亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=1194384043","media":"老虎资讯综合","summary":"5月12日,Hims & Hers Health盘后暴跌逾12%!第一季度盈利未达预期,出现亏损,原因是其美国业务疲软抵消了海外业务的增长。2026年第一季度营收为6.081亿美元,高于2025年第一季度的5.86亿美元,同比增长4%。今年2月,该公司推出了诺和诺德公司Wegovy片剂的仿制药,但由于诺和诺德提起诉讼以及监管机构加强审查,该公司随后撤回了该产品。目前,该公司与诺和诺德合作分销其品牌的GLP-1受体激动剂,并同意停止销售其自身价格更低、利润更高的替代产品。","content":"<html><head></head><body><p>5月12日,Hims & Hers Health盘后暴跌逾12%!第一季度盈利未达预期,出现亏损,原因是其美国业务疲软抵消了海外业务的增长。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c375e621c745efab067bf11cfe8919fc\" tg-width=\"837\" tg-height=\"726\"/></p><p>该公司公布2026年第一季度净亏损9210万美元,即每股亏损0.40美元,而2025年第一季度净利润为4950万美元,即每股收益0.20美元。分析师平均预期每股盈利0.01美元。</p><p style=\"text-align: start;\">2026年第一季度营收为6.081亿美元,高于2025年第一季度的5.86亿美元,同比增长4%。然而,这一数字低于分析师预期的6.165亿美元。其来自美洲地区的营收同比下降8%至5.299亿美元。 </p><p style=\"text-align: start;\">今年2月,该公司推出了诺和诺德公司Wegovy片剂的仿制药,但由于诺和诺德提起诉讼以及监管机构加强审查,该公司随后撤回了该产品。目前,该公司与诺和诺德合作分销其品牌的GLP-1受体激动剂,并同意停止销售其自身价格更低、利润更高的替代产品。 </p><p style=\"text-align: start;\">“第一季度,我们进行了战略调整,扩大了品牌GLP-1产品的范围,早期需求信号显示,我们的消费者覆盖面正在显著扩大,”首席财务官Yemi Okupe表示。“我们拥有近260万订阅用户,涵盖众多专业领域,这使我们能够投资于技术和运营,从而充分利用我们的闭环生态系统。” </p><p>不过,该公司提高了 2026 年的收入预期,押注其个性化医疗保健产品的销售额将会增加。</p><p style=\"text-align: start;\">该公司目前预计年收入在 28 亿美元至 30 亿美元之间,而此前的预测为 27 亿美元至 29 亿美元。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers Health Q1营收同比增长4%,但盈利未达预期出现亏损</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers Health Q1营收同比增长4%,但盈利未达预期出现亏损\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2026-05-12 06:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>5月12日,Hims & Hers Health盘后暴跌逾12%!第一季度盈利未达预期,出现亏损,原因是其美国业务疲软抵消了海外业务的增长。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c375e621c745efab067bf11cfe8919fc\" tg-width=\"837\" tg-height=\"726\"/></p><p>该公司公布2026年第一季度净亏损9210万美元,即每股亏损0.40美元,而2025年第一季度净利润为4950万美元,即每股收益0.20美元。分析师平均预期每股盈利0.01美元。</p><p style=\"text-align: start;\">2026年第一季度营收为6.081亿美元,高于2025年第一季度的5.86亿美元,同比增长4%。然而,这一数字低于分析师预期的6.165亿美元。其来自美洲地区的营收同比下降8%至5.299亿美元。 </p><p style=\"text-align: start;\">今年2月,该公司推出了诺和诺德公司Wegovy片剂的仿制药,但由于诺和诺德提起诉讼以及监管机构加强审查,该公司随后撤回了该产品。目前,该公司与诺和诺德合作分销其品牌的GLP-1受体激动剂,并同意停止销售其自身价格更低、利润更高的替代产品。 </p><p style=\"text-align: start;\">“第一季度,我们进行了战略调整,扩大了品牌GLP-1产品的范围,早期需求信号显示,我们的消费者覆盖面正在显著扩大,”首席财务官Yemi Okupe表示。“我们拥有近260万订阅用户,涵盖众多专业领域,这使我们能够投资于技术和运营,从而充分利用我们的闭环生态系统。” </p><p>不过,该公司提高了 2026 年的收入预期,押注其个性化医疗保健产品的销售额将会增加。</p><p style=\"text-align: start;\">该公司目前预计年收入在 28 亿美元至 30 亿美元之间,而此前的预测为 27 亿美元至 29 亿美元。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f3698e3114ac0a5c39dcf7c045f5aaf4","relate_stocks":{"HIMY":"Defiance Leveraged Long + Income HIMS ETF","HIYY":"YieldMax HIMS Option Income Strategy ETF","HMYY":"GraniteShares YieldBoost HIMS ETF","HIMZ":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF","HIMS":"Hims & Hers Health Inc."},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194384043","content_text":"5月12日,Hims & Hers Health盘后暴跌逾12%!第一季度盈利未达预期,出现亏损,原因是其美国业务疲软抵消了海外业务的增长。该公司公布2026年第一季度净亏损9210万美元,即每股亏损0.40美元,而2025年第一季度净利润为4950万美元,即每股收益0.20美元。分析师平均预期每股盈利0.01美元。2026年第一季度营收为6.081亿美元,高于2025年第一季度的5.86亿美元,同比增长4%。然而,这一数字低于分析师预期的6.165亿美元。其来自美洲地区的营收同比下降8%至5.299亿美元。 今年2月,该公司推出了诺和诺德公司Wegovy片剂的仿制药,但由于诺和诺德提起诉讼以及监管机构加强审查,该公司随后撤回了该产品。目前,该公司与诺和诺德合作分销其品牌的GLP-1受体激动剂,并同意停止销售其自身价格更低、利润更高的替代产品。 “第一季度,我们进行了战略调整,扩大了品牌GLP-1产品的范围,早期需求信号显示,我们的消费者覆盖面正在显著扩大,”首席财务官Yemi Okupe表示。“我们拥有近260万订阅用户,涵盖众多专业领域,这使我们能够投资于技术和运营,从而充分利用我们的闭环生态系统。” 不过,该公司提高了 2026 年的收入预期,押注其个性化医疗保健产品的销售额将会增加。该公司目前预计年收入在 28 亿美元至 30 亿美元之间,而此前的预测为 27 亿美元至 29 亿美元。","news_type":1,"symbols_score_info":{"HIYY":0.6,"HIMZ":0.6,"HMYY":0.6,"HIMS":2,"HIMY":0.6}},"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4195019739358082","authorId":"4195019739358082","name":"万亿火箭兵","avatar":"https://static.tigerbbs.com/72269d2c0cdd33bef47d08880161d7e8","crmLevel":1,"crmLevelSwitch":0,"idStr":"4195019739358082","authorIdStr":"4195019739358082"},"content":"盘后就撤了,财报预期不行,损点离场,博弈财报就是这样的,没有100%只有损点先行利润仔在后。","text":"盘后就撤了,财报预期不行,损点离场,博弈财报就是这样的,没有100%只有损点先行利润仔在后。","html":"盘后就撤了,财报预期不行,损点离场,博弈财报就是这样的,没有100%只有损点先行利润仔在后。"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":561447131054144,"gmtCreate":1778103742084,"gmtModify":1778103812931,"author":{"id":"3483668508098944","authorId":"3483668508098944","name":"我是你的好朋友","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483668508098944","authorIdStr":"3483668508098944"},"themes":[],"title":"","htmlText":"厉害的,今天选择清仓先!OKLO高于80属于风险区间了","listText":"厉害的,今天选择清仓先!OKLO高于80属于风险区间了","text":"厉害的,今天选择清仓先!OKLO高于80属于风险区间了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/561447131054144","repostId":"561423902224512","repostType":1,"isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":559558826582168,"gmtCreate":1777642831387,"gmtModify":1777642888971,"author":{"id":"3483668508098944","authorId":"3483668508098944","name":"我是你的好朋友","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483668508098944","authorIdStr":"3483668508098944"},"themes":[],"title":"","htmlText":"牛啊!你卖的这几个都不错,我只买了OKLO,强烈看好突破80的阻力位,目标价100.","listText":"牛啊!你卖的这几个都不错,我只买了OKLO,强烈看好突破80的阻力位,目标价100.","text":"牛啊!你卖的这几个都不错,我只买了OKLO,强烈看好突破80的阻力位,目标价100.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/559558826582168","repostId":"559359589185384","repostType":1,"repost":{"id":559359589185384,"gmtCreate":1777594175409,"gmtModify":1777597096291,"author":{"id":"4195019739358082","authorId":"4195019739358082","name":"万亿火箭兵","avatar":"https://static.tigerbbs.com/72269d2c0cdd33bef47d08880161d7e8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4195019739358082","authorIdStr":"4195019739358082"},"themes":[],"title":"","htmlText":"🔥(5.1)美股盘后分析| 赛道为王,持仓全线爆发 📈一、市场反弹核心因素拆解 昨夜美股三大指数集体收涨,道指涨1.62%、标普500涨1.02%、纳指涨0.89%,纳指与标普再创历史新高✨,科技股形成分化,但大部分板块和个股明显反弹,核心驱动因素拆解: 1. 📊财报超预期,AI商业化兑现:谷歌财报爆冷,云AI收入增63%,股价涨近10%;亚马逊云业务增速创四年新高,带动市场情绪。科技股分化源于AI投入与回报的平衡,高变现、低资本压力标的受追捧。 2. 💹宏观面稳定,经济韧性强:美联储维持利率不变(3.50%-3.75%),符合预期;美国一季度GDP增2%,初请失业金人数低位,经济软着陆预期升温。 3. ⛽油价回落,通胀压力缓解:国际油价大跌超2%,消除通胀隐忧,成长股估值修复。 4. 💵月末资金回流,做多情绪集中释放:4月美股月度涨幅创近年最佳,最后交易日资金回流,推动普涨。 🚀二、持仓全线暴涨,浮动盈亏速览 持仓四只标的集体大涨,最弱涨幅超7%,OKLO开盘暴力拉升超11%,完美印证赛道逻辑✅: • 🚀<a href=\"https://laohu8.com/S/RKLB\">$Rocket Inc.(RKLB)$ </a> (成本70-72):收盘价82.51,涨幅7.13% 浮动盈利:10.51-12.51美元/股,盈利率+14.6%-17.9% • ⚛️<a href=\"https://laohu8.com/S/IONQ\">$IONQ Inc.(IONQ)$ </a> (成本44.8):收盘价45.15,涨幅7.2% 浮动盈利:0.35美元/股,盈利率+0.78% • 💥<a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a> (成本70):开盘拉升","listText":"🔥(5.1)美股盘后分析| 赛道为王,持仓全线爆发 📈一、市场反弹核心因素拆解 昨夜美股三大指数集体收涨,道指涨1.62%、标普500涨1.02%、纳指涨0.89%,纳指与标普再创历史新高✨,科技股形成分化,但大部分板块和个股明显反弹,核心驱动因素拆解: 1. 📊财报超预期,AI商业化兑现:谷歌财报爆冷,云AI收入增63%,股价涨近10%;亚马逊云业务增速创四年新高,带动市场情绪。科技股分化源于AI投入与回报的平衡,高变现、低资本压力标的受追捧。 2. 💹宏观面稳定,经济韧性强:美联储维持利率不变(3.50%-3.75%),符合预期;美国一季度GDP增2%,初请失业金人数低位,经济软着陆预期升温。 3. ⛽油价回落,通胀压力缓解:国际油价大跌超2%,消除通胀隐忧,成长股估值修复。 4. 💵月末资金回流,做多情绪集中释放:4月美股月度涨幅创近年最佳,最后交易日资金回流,推动普涨。 🚀二、持仓全线暴涨,浮动盈亏速览 持仓四只标的集体大涨,最弱涨幅超7%,OKLO开盘暴力拉升超11%,完美印证赛道逻辑✅: • 🚀<a href=\"https://laohu8.com/S/RKLB\">$Rocket Inc.(RKLB)$ </a> (成本70-72):收盘价82.51,涨幅7.13% 浮动盈利:10.51-12.51美元/股,盈利率+14.6%-17.9% • ⚛️<a href=\"https://laohu8.com/S/IONQ\">$IONQ Inc.(IONQ)$ </a> (成本44.8):收盘价45.15,涨幅7.2% 浮动盈利:0.35美元/股,盈利率+0.78% • 💥<a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a> (成本70):开盘拉升","text":"🔥(5.1)美股盘后分析| 赛道为王,持仓全线爆发 📈一、市场反弹核心因素拆解 昨夜美股三大指数集体收涨,道指涨1.62%、标普500涨1.02%、纳指涨0.89%,纳指与标普再创历史新高✨,科技股形成分化,但大部分板块和个股明显反弹,核心驱动因素拆解: 1. 📊财报超预期,AI商业化兑现:谷歌财报爆冷,云AI收入增63%,股价涨近10%;亚马逊云业务增速创四年新高,带动市场情绪。科技股分化源于AI投入与回报的平衡,高变现、低资本压力标的受追捧。 2. 💹宏观面稳定,经济韧性强:美联储维持利率不变(3.50%-3.75%),符合预期;美国一季度GDP增2%,初请失业金人数低位,经济软着陆预期升温。 3. ⛽油价回落,通胀压力缓解:国际油价大跌超2%,消除通胀隐忧,成长股估值修复。 4. 💵月末资金回流,做多情绪集中释放:4月美股月度涨幅创近年最佳,最后交易日资金回流,推动普涨。 🚀二、持仓全线暴涨,浮动盈亏速览 持仓四只标的集体大涨,最弱涨幅超7%,OKLO开盘暴力拉升超11%,完美印证赛道逻辑✅: • 🚀$Rocket Inc.(RKLB)$ (成本70-72):收盘价82.51,涨幅7.13% 浮动盈利:10.51-12.51美元/股,盈利率+14.6%-17.9% • ⚛️$IONQ Inc.(IONQ)$ (成本44.8):收盘价45.15,涨幅7.2% 浮动盈利:0.35美元/股,盈利率+0.78% • 💥$Oklo Inc.(OKLO)$ (成本70):开盘拉升","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/559359589185384","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":559228291270328,"gmtCreate":1777562106239,"gmtModify":1777562319778,"author":{"id":"3483668508098944","authorId":"3483668508098944","name":"我是你的好朋友","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483668508098944","authorIdStr":"3483668508098944"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a> Oklo近期与英伟达及洛斯阿拉莫斯国家实验室达成三方合作,将利用AI数字孪生技术加速核燃料研发与验证,为“核能供电AI工厂”铺路。此外,汇丰银行以买入评级及96美元目标价首次覆盖该公司,Tigress Financial也给予买入评级及130美元目标价。 本人分批买入,目前满仓!","listText":"<a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a> Oklo近期与英伟达及洛斯阿拉莫斯国家实验室达成三方合作,将利用AI数字孪生技术加速核燃料研发与验证,为“核能供电AI工厂”铺路。此外,汇丰银行以买入评级及96美元目标价首次覆盖该公司,Tigress Financial也给予买入评级及130美元目标价。 本人分批买入,目前满仓!","text":"$Oklo Inc.(OKLO)$ Oklo近期与英伟达及洛斯阿拉莫斯国家实验室达成三方合作,将利用AI数字孪生技术加速核燃料研发与验证,为“核能供电AI工厂”铺路。此外,汇丰银行以买入评级及96美元目标价首次覆盖该公司,Tigress Financial也给予买入评级及130美元目标价。 本人分批买入,目前满仓!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/559228291270328","isVote":1,"tweetType":1,"viewCount":1235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":484856729575488,"gmtCreate":1759402289561,"gmtModify":1759403656771,"author":{"id":"3483668508098944","authorId":"3483668508098944","name":"我是你的好朋友","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483668508098944","authorIdStr":"3483668508098944"},"themes":[],"title":"","htmlText":"国庆节快乐!我没上车啊","listText":"国庆节快乐!我没上车啊","text":"国庆节快乐!我没上车啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/484856729575488","isVote":1,"tweetType":1,"viewCount":1759,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":563247321208184,"gmtCreate":1778540112943,"gmtModify":1778540115720,"author":{"id":"3483668508098944","authorId":"3483668508098944","name":"我是你的好朋友","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483668508098944","authorIdStr":"3483668508098944"},"themes":[],"title":"","htmlText":"完犊了吧?是不是不行了?<a href=\"https://laohu8.com/U/4195019739358082\">@万亿火箭兵 </a>","listText":"完犊了吧?是不是不行了?<a href=\"https://laohu8.com/U/4195019739358082\">@万亿火箭兵 </a>","text":"完犊了吧?是不是不行了?@万亿火箭兵 ","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/563247321208184","repostId":"1194384043","repostType":2,"repost":{"id":"1194384043","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1778538229,"share":"https://www.laohu8.com/m/news/1194384043?lang=zh_CN&edition=full","pubTime":"2026-05-12 06:23","market":"us","language":"zh","title":"Hims & Hers Health Q1营收同比增长4%,但盈利未达预期出现亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=1194384043","media":"老虎资讯综合","summary":"5月12日,Hims & Hers Health盘后暴跌逾12%!第一季度盈利未达预期,出现亏损,原因是其美国业务疲软抵消了海外业务的增长。2026年第一季度营收为6.081亿美元,高于2025年第一季度的5.86亿美元,同比增长4%。今年2月,该公司推出了诺和诺德公司Wegovy片剂的仿制药,但由于诺和诺德提起诉讼以及监管机构加强审查,该公司随后撤回了该产品。目前,该公司与诺和诺德合作分销其品牌的GLP-1受体激动剂,并同意停止销售其自身价格更低、利润更高的替代产品。","content":"<html><head></head><body><p>5月12日,Hims & Hers Health盘后暴跌逾12%!第一季度盈利未达预期,出现亏损,原因是其美国业务疲软抵消了海外业务的增长。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c375e621c745efab067bf11cfe8919fc\" tg-width=\"837\" tg-height=\"726\"/></p><p>该公司公布2026年第一季度净亏损9210万美元,即每股亏损0.40美元,而2025年第一季度净利润为4950万美元,即每股收益0.20美元。分析师平均预期每股盈利0.01美元。</p><p style=\"text-align: start;\">2026年第一季度营收为6.081亿美元,高于2025年第一季度的5.86亿美元,同比增长4%。然而,这一数字低于分析师预期的6.165亿美元。其来自美洲地区的营收同比下降8%至5.299亿美元。 </p><p style=\"text-align: start;\">今年2月,该公司推出了诺和诺德公司Wegovy片剂的仿制药,但由于诺和诺德提起诉讼以及监管机构加强审查,该公司随后撤回了该产品。目前,该公司与诺和诺德合作分销其品牌的GLP-1受体激动剂,并同意停止销售其自身价格更低、利润更高的替代产品。 </p><p style=\"text-align: start;\">“第一季度,我们进行了战略调整,扩大了品牌GLP-1产品的范围,早期需求信号显示,我们的消费者覆盖面正在显著扩大,”首席财务官Yemi Okupe表示。“我们拥有近260万订阅用户,涵盖众多专业领域,这使我们能够投资于技术和运营,从而充分利用我们的闭环生态系统。” </p><p>不过,该公司提高了 2026 年的收入预期,押注其个性化医疗保健产品的销售额将会增加。</p><p style=\"text-align: start;\">该公司目前预计年收入在 28 亿美元至 30 亿美元之间,而此前的预测为 27 亿美元至 29 亿美元。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers Health Q1营收同比增长4%,但盈利未达预期出现亏损</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers Health Q1营收同比增长4%,但盈利未达预期出现亏损\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2026-05-12 06:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>5月12日,Hims & Hers Health盘后暴跌逾12%!第一季度盈利未达预期,出现亏损,原因是其美国业务疲软抵消了海外业务的增长。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c375e621c745efab067bf11cfe8919fc\" tg-width=\"837\" tg-height=\"726\"/></p><p>该公司公布2026年第一季度净亏损9210万美元,即每股亏损0.40美元,而2025年第一季度净利润为4950万美元,即每股收益0.20美元。分析师平均预期每股盈利0.01美元。</p><p style=\"text-align: start;\">2026年第一季度营收为6.081亿美元,高于2025年第一季度的5.86亿美元,同比增长4%。然而,这一数字低于分析师预期的6.165亿美元。其来自美洲地区的营收同比下降8%至5.299亿美元。 </p><p style=\"text-align: start;\">今年2月,该公司推出了诺和诺德公司Wegovy片剂的仿制药,但由于诺和诺德提起诉讼以及监管机构加强审查,该公司随后撤回了该产品。目前,该公司与诺和诺德合作分销其品牌的GLP-1受体激动剂,并同意停止销售其自身价格更低、利润更高的替代产品。 </p><p style=\"text-align: start;\">“第一季度,我们进行了战略调整,扩大了品牌GLP-1产品的范围,早期需求信号显示,我们的消费者覆盖面正在显著扩大,”首席财务官Yemi Okupe表示。“我们拥有近260万订阅用户,涵盖众多专业领域,这使我们能够投资于技术和运营,从而充分利用我们的闭环生态系统。” </p><p>不过,该公司提高了 2026 年的收入预期,押注其个性化医疗保健产品的销售额将会增加。</p><p style=\"text-align: start;\">该公司目前预计年收入在 28 亿美元至 30 亿美元之间,而此前的预测为 27 亿美元至 29 亿美元。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f3698e3114ac0a5c39dcf7c045f5aaf4","relate_stocks":{"HIMY":"Defiance Leveraged Long + Income HIMS ETF","HIYY":"YieldMax HIMS Option Income Strategy ETF","HMYY":"GraniteShares YieldBoost HIMS ETF","HIMZ":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF","HIMS":"Hims & Hers Health Inc."},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194384043","content_text":"5月12日,Hims & Hers Health盘后暴跌逾12%!第一季度盈利未达预期,出现亏损,原因是其美国业务疲软抵消了海外业务的增长。该公司公布2026年第一季度净亏损9210万美元,即每股亏损0.40美元,而2025年第一季度净利润为4950万美元,即每股收益0.20美元。分析师平均预期每股盈利0.01美元。2026年第一季度营收为6.081亿美元,高于2025年第一季度的5.86亿美元,同比增长4%。然而,这一数字低于分析师预期的6.165亿美元。其来自美洲地区的营收同比下降8%至5.299亿美元。 今年2月,该公司推出了诺和诺德公司Wegovy片剂的仿制药,但由于诺和诺德提起诉讼以及监管机构加强审查,该公司随后撤回了该产品。目前,该公司与诺和诺德合作分销其品牌的GLP-1受体激动剂,并同意停止销售其自身价格更低、利润更高的替代产品。 “第一季度,我们进行了战略调整,扩大了品牌GLP-1产品的范围,早期需求信号显示,我们的消费者覆盖面正在显著扩大,”首席财务官Yemi Okupe表示。“我们拥有近260万订阅用户,涵盖众多专业领域,这使我们能够投资于技术和运营,从而充分利用我们的闭环生态系统。” 不过,该公司提高了 2026 年的收入预期,押注其个性化医疗保健产品的销售额将会增加。该公司目前预计年收入在 28 亿美元至 30 亿美元之间,而此前的预测为 27 亿美元至 29 亿美元。","news_type":1,"symbols_score_info":{"HIYY":0.6,"HIMZ":0.6,"HMYY":0.6,"HIMS":2,"HIMY":0.6}},"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4195019739358082","authorId":"4195019739358082","name":"万亿火箭兵","avatar":"https://static.tigerbbs.com/72269d2c0cdd33bef47d08880161d7e8","crmLevel":1,"crmLevelSwitch":0,"idStr":"4195019739358082","authorIdStr":"4195019739358082"},"content":"盘后就撤了,财报预期不行,损点离场,博弈财报就是这样的,没有100%只有损点先行利润仔在后。","text":"盘后就撤了,财报预期不行,损点离场,博弈财报就是这样的,没有100%只有损点先行利润仔在后。","html":"盘后就撤了,财报预期不行,损点离场,博弈财报就是这样的,没有100%只有损点先行利润仔在后。"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":561447131054144,"gmtCreate":1778103742084,"gmtModify":1778103812931,"author":{"id":"3483668508098944","authorId":"3483668508098944","name":"我是你的好朋友","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483668508098944","authorIdStr":"3483668508098944"},"themes":[],"title":"","htmlText":"厉害的,今天选择清仓先!OKLO高于80属于风险区间了","listText":"厉害的,今天选择清仓先!OKLO高于80属于风险区间了","text":"厉害的,今天选择清仓先!OKLO高于80属于风险区间了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/561447131054144","repostId":"561423902224512","repostType":1,"isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":564510616967064,"gmtCreate":1778854366229,"gmtModify":1778855152456,"author":{"id":"3483668508098944","authorId":"3483668508098944","name":"我是你的好朋友","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483668508098944","authorIdStr":"3483668508098944"},"themes":[],"title":"","htmlText":"OKLO有点完犊子了,下跌的比较狠,这一次的扩股,到底是风险还是机遇?这对于当前股价来说,是个很坏很坏的消息。","listText":"OKLO有点完犊子了,下跌的比较狠,这一次的扩股,到底是风险还是机遇?这对于当前股价来说,是个很坏很坏的消息。","text":"OKLO有点完犊子了,下跌的比较狠,这一次的扩股,到底是风险还是机遇?这对于当前股价来说,是个很坏很坏的消息。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/564510616967064","repostId":"564275408799536","repostType":1,"repost":{"id":564275408799536,"gmtCreate":1778796941888,"gmtModify":1778796947209,"author":{"id":"4235754457199412","authorId":"4235754457199412","name":"请叫我瞳哥","avatar":"https://static.tigerbbs.com/913539812ee1ad056132f12f82e124b3","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4235754457199412","authorIdStr":"4235754457199412"},"themes":[],"title":"","htmlText":"洗盘不用慌!暗藏拐点,二次拉升即将启动😮💨 5.14美股指数创新高,但小票集体分歧洗盘,最近持仓确实拿得很磨人,大家心态别崩! <a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a> <a href=\"https://laohu8.com/S/NNE\">$NANO Inc(NNE)$ </a> <a href=\"https://laohu8.com/S/RGTI\">$Rigetti Computing(RGTI)$ </a> 4只持仓整体趋势全部守住,没有破位走坏,属于正常情绪回调蓄力🛡️ OKLO短期持续回踩,接下来重点观察2-3个交易日,能否站稳30日均线上方企稳反弹,站稳就是新一轮机会。 NNE盘后出炉重磅财报,整体大幅超预期!亏损明显收窄,基本面持续变好。 目前仍在研发商业化阶段,盘后小幅上涨4%,估值修复行情值得博弈。 现在就是拉升前最后洗盘,逻辑全部在线,耐心持股坐等反攻就行! 大家手里都拿了哪只?成本多少?评论区抱团一起等大涨🔥","listText":"洗盘不用慌!暗藏拐点,二次拉升即将启动😮💨 5.14美股指数创新高,但小票集体分歧洗盘,最近持仓确实拿得很磨人,大家心态别崩! <a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a> <a href=\"https://laohu8.com/S/NNE\">$NANO Inc(NNE)$ </a> <a href=\"https://laohu8.com/S/RGTI\">$Rigetti Computing(RGTI)$ </a> 4只持仓整体趋势全部守住,没有破位走坏,属于正常情绪回调蓄力🛡️ OKLO短期持续回踩,接下来重点观察2-3个交易日,能否站稳30日均线上方企稳反弹,站稳就是新一轮机会。 NNE盘后出炉重磅财报,整体大幅超预期!亏损明显收窄,基本面持续变好。 目前仍在研发商业化阶段,盘后小幅上涨4%,估值修复行情值得博弈。 现在就是拉升前最后洗盘,逻辑全部在线,耐心持股坐等反攻就行! 大家手里都拿了哪只?成本多少?评论区抱团一起等大涨🔥","text":"洗盘不用慌!暗藏拐点,二次拉升即将启动😮💨 5.14美股指数创新高,但小票集体分歧洗盘,最近持仓确实拿得很磨人,大家心态别崩! $Oklo Inc.(OKLO)$ $NANO Inc(NNE)$ $Rigetti Computing(RGTI)$ 4只持仓整体趋势全部守住,没有破位走坏,属于正常情绪回调蓄力🛡️ OKLO短期持续回踩,接下来重点观察2-3个交易日,能否站稳30日均线上方企稳反弹,站稳就是新一轮机会。 NNE盘后出炉重磅财报,整体大幅超预期!亏损明显收窄,基本面持续变好。 目前仍在研发商业化阶段,盘后小幅上涨4%,估值修复行情值得博弈。 现在就是拉升前最后洗盘,逻辑全部在线,耐心持股坐等反攻就行! 大家手里都拿了哪只?成本多少?评论区抱团一起等大涨🔥","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/564275408799536","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":563815670052104,"gmtCreate":1778684639492,"gmtModify":1778684642064,"author":{"id":"3483668508098944","authorId":"3483668508098944","name":"我是你的好朋友","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483668508098944","authorIdStr":"3483668508098944"},"themes":[],"title":"","htmlText":"今天买入okll,成本价9.9","listText":"今天买入okll,成本价9.9","text":"今天买入okll,成本价9.9","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/563815670052104","repostId":"563761791694632","repostType":1,"repost":{"id":563761791694632,"gmtCreate":1778671547058,"gmtModify":1778676249145,"author":{"id":"4235754457199412","authorId":"4235754457199412","name":"请叫我瞳哥","avatar":"https://static.tigerbbs.com/913539812ee1ad056132f12f82e124b3","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4235754457199412","authorIdStr":"4235754457199412"},"themes":[],"title":"","htmlText":"📊5.13 盘前|通胀扰动震荡消化,航天军工企稳待突破✨ 【📰盘前资讯】 隔夜美股涨跌分化,道指小幅收涨,纳指、标普小幅回落,市场受超预期4月CPI数据扰动,通胀担忧小幅升温。美债收益率小幅上行,资金高低切换明显,高位科技股获利回吐,低位题材、财报催化小票承接强势。今日盘前期指小幅回暖,整体维持结构性震荡行情,无系统性风险,操作继续聚焦企稳突破+财报潜伏机会。 【🔥今日主线】 ✅ 航天国防航空:连续洗盘缩量企稳,板块承接扎实,短线突破窗口临近 ✅ 财报催化小票:业绩预期落地,低位潜伏标的迎来修复行情 ✅ 科技细分赛道:分歧震荡消化,回踩企稳低吸为主,不追高博弈 【💡操作思路】 坚守只做放量突破、缩量企稳优质标的原则,规避弱势阴跌个股。 震荡市严格控仓,持仓带好止损止盈,不扛单、不贪回撤。 优先布局形态修复完成、有财报/题材催化的低位标的,抓确定性短线行情。 【📈持仓策略】 ✅OKLO<a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a><v-v data-views=\"1\"></v-v> 成本:69 昨日收盘价:73.6 浮盈:+6.7% 止损:上调至成本69 目标:100+ 现状:昨日深度洗盘但日内承接极强,属于典型诱空洗盘,多头趋势完全守住,筹码未松动,静待后续趋势拉升+情绪共振🚀 ✅Carmell Therapeutics(CRML) 成本:11.5 昨日收盘价:11.87 浮盈:+3.2% 止损:10.3 目标:15.5 / 18 现状:小幅震荡洗盘蓄力,下方均线支撑稳固,抛压持续衰竭,形态保持强势,随时开启反弹修复行情📊 ✅RGTI<a href=\"https://laohu8.com/S/RGTI\">$Rigetti Computing(RGTI)$ </a>","listText":"📊5.13 盘前|通胀扰动震荡消化,航天军工企稳待突破✨ 【📰盘前资讯】 隔夜美股涨跌分化,道指小幅收涨,纳指、标普小幅回落,市场受超预期4月CPI数据扰动,通胀担忧小幅升温。美债收益率小幅上行,资金高低切换明显,高位科技股获利回吐,低位题材、财报催化小票承接强势。今日盘前期指小幅回暖,整体维持结构性震荡行情,无系统性风险,操作继续聚焦企稳突破+财报潜伏机会。 【🔥今日主线】 ✅ 航天国防航空:连续洗盘缩量企稳,板块承接扎实,短线突破窗口临近 ✅ 财报催化小票:业绩预期落地,低位潜伏标的迎来修复行情 ✅ 科技细分赛道:分歧震荡消化,回踩企稳低吸为主,不追高博弈 【💡操作思路】 坚守只做放量突破、缩量企稳优质标的原则,规避弱势阴跌个股。 震荡市严格控仓,持仓带好止损止盈,不扛单、不贪回撤。 优先布局形态修复完成、有财报/题材催化的低位标的,抓确定性短线行情。 【📈持仓策略】 ✅OKLO<a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a><v-v data-views=\"1\"></v-v> 成本:69 昨日收盘价:73.6 浮盈:+6.7% 止损:上调至成本69 目标:100+ 现状:昨日深度洗盘但日内承接极强,属于典型诱空洗盘,多头趋势完全守住,筹码未松动,静待后续趋势拉升+情绪共振🚀 ✅Carmell Therapeutics(CRML) 成本:11.5 昨日收盘价:11.87 浮盈:+3.2% 止损:10.3 目标:15.5 / 18 现状:小幅震荡洗盘蓄力,下方均线支撑稳固,抛压持续衰竭,形态保持强势,随时开启反弹修复行情📊 ✅RGTI<a href=\"https://laohu8.com/S/RGTI\">$Rigetti Computing(RGTI)$ </a>","text":"📊5.13 盘前|通胀扰动震荡消化,航天军工企稳待突破✨ 【📰盘前资讯】 隔夜美股涨跌分化,道指小幅收涨,纳指、标普小幅回落,市场受超预期4月CPI数据扰动,通胀担忧小幅升温。美债收益率小幅上行,资金高低切换明显,高位科技股获利回吐,低位题材、财报催化小票承接强势。今日盘前期指小幅回暖,整体维持结构性震荡行情,无系统性风险,操作继续聚焦企稳突破+财报潜伏机会。 【🔥今日主线】 ✅ 航天国防航空:连续洗盘缩量企稳,板块承接扎实,短线突破窗口临近 ✅ 财报催化小票:业绩预期落地,低位潜伏标的迎来修复行情 ✅ 科技细分赛道:分歧震荡消化,回踩企稳低吸为主,不追高博弈 【💡操作思路】 坚守只做放量突破、缩量企稳优质标的原则,规避弱势阴跌个股。 震荡市严格控仓,持仓带好止损止盈,不扛单、不贪回撤。 优先布局形态修复完成、有财报/题材催化的低位标的,抓确定性短线行情。 【📈持仓策略】 ✅OKLO$Oklo Inc.(OKLO)$ 成本:69 昨日收盘价:73.6 浮盈:+6.7% 止损:上调至成本69 目标:100+ 现状:昨日深度洗盘但日内承接极强,属于典型诱空洗盘,多头趋势完全守住,筹码未松动,静待后续趋势拉升+情绪共振🚀 ✅Carmell Therapeutics(CRML) 成本:11.5 昨日收盘价:11.87 浮盈:+3.2% 止损:10.3 目标:15.5 / 18 现状:小幅震荡洗盘蓄力,下方均线支撑稳固,抛压持续衰竭,形态保持强势,随时开启反弹修复行情📊 ✅RGTI$Rigetti Computing(RGTI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/563761791694632","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":154,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":559558826582168,"gmtCreate":1777642831387,"gmtModify":1777642888971,"author":{"id":"3483668508098944","authorId":"3483668508098944","name":"我是你的好朋友","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483668508098944","authorIdStr":"3483668508098944"},"themes":[],"title":"","htmlText":"牛啊!你卖的这几个都不错,我只买了OKLO,强烈看好突破80的阻力位,目标价100.","listText":"牛啊!你卖的这几个都不错,我只买了OKLO,强烈看好突破80的阻力位,目标价100.","text":"牛啊!你卖的这几个都不错,我只买了OKLO,强烈看好突破80的阻力位,目标价100.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/559558826582168","repostId":"559359589185384","repostType":1,"repost":{"id":559359589185384,"gmtCreate":1777594175409,"gmtModify":1777597096291,"author":{"id":"4195019739358082","authorId":"4195019739358082","name":"万亿火箭兵","avatar":"https://static.tigerbbs.com/72269d2c0cdd33bef47d08880161d7e8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4195019739358082","authorIdStr":"4195019739358082"},"themes":[],"title":"","htmlText":"🔥(5.1)美股盘后分析| 赛道为王,持仓全线爆发 📈一、市场反弹核心因素拆解 昨夜美股三大指数集体收涨,道指涨1.62%、标普500涨1.02%、纳指涨0.89%,纳指与标普再创历史新高✨,科技股形成分化,但大部分板块和个股明显反弹,核心驱动因素拆解: 1. 📊财报超预期,AI商业化兑现:谷歌财报爆冷,云AI收入增63%,股价涨近10%;亚马逊云业务增速创四年新高,带动市场情绪。科技股分化源于AI投入与回报的平衡,高变现、低资本压力标的受追捧。 2. 💹宏观面稳定,经济韧性强:美联储维持利率不变(3.50%-3.75%),符合预期;美国一季度GDP增2%,初请失业金人数低位,经济软着陆预期升温。 3. ⛽油价回落,通胀压力缓解:国际油价大跌超2%,消除通胀隐忧,成长股估值修复。 4. 💵月末资金回流,做多情绪集中释放:4月美股月度涨幅创近年最佳,最后交易日资金回流,推动普涨。 🚀二、持仓全线暴涨,浮动盈亏速览 持仓四只标的集体大涨,最弱涨幅超7%,OKLO开盘暴力拉升超11%,完美印证赛道逻辑✅: • 🚀<a href=\"https://laohu8.com/S/RKLB\">$Rocket Inc.(RKLB)$ </a> (成本70-72):收盘价82.51,涨幅7.13% 浮动盈利:10.51-12.51美元/股,盈利率+14.6%-17.9% • ⚛️<a href=\"https://laohu8.com/S/IONQ\">$IONQ Inc.(IONQ)$ </a> (成本44.8):收盘价45.15,涨幅7.2% 浮动盈利:0.35美元/股,盈利率+0.78% • 💥<a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a> (成本70):开盘拉升","listText":"🔥(5.1)美股盘后分析| 赛道为王,持仓全线爆发 📈一、市场反弹核心因素拆解 昨夜美股三大指数集体收涨,道指涨1.62%、标普500涨1.02%、纳指涨0.89%,纳指与标普再创历史新高✨,科技股形成分化,但大部分板块和个股明显反弹,核心驱动因素拆解: 1. 📊财报超预期,AI商业化兑现:谷歌财报爆冷,云AI收入增63%,股价涨近10%;亚马逊云业务增速创四年新高,带动市场情绪。科技股分化源于AI投入与回报的平衡,高变现、低资本压力标的受追捧。 2. 💹宏观面稳定,经济韧性强:美联储维持利率不变(3.50%-3.75%),符合预期;美国一季度GDP增2%,初请失业金人数低位,经济软着陆预期升温。 3. ⛽油价回落,通胀压力缓解:国际油价大跌超2%,消除通胀隐忧,成长股估值修复。 4. 💵月末资金回流,做多情绪集中释放:4月美股月度涨幅创近年最佳,最后交易日资金回流,推动普涨。 🚀二、持仓全线暴涨,浮动盈亏速览 持仓四只标的集体大涨,最弱涨幅超7%,OKLO开盘暴力拉升超11%,完美印证赛道逻辑✅: • 🚀<a href=\"https://laohu8.com/S/RKLB\">$Rocket Inc.(RKLB)$ </a> (成本70-72):收盘价82.51,涨幅7.13% 浮动盈利:10.51-12.51美元/股,盈利率+14.6%-17.9% • ⚛️<a href=\"https://laohu8.com/S/IONQ\">$IONQ Inc.(IONQ)$ </a> (成本44.8):收盘价45.15,涨幅7.2% 浮动盈利:0.35美元/股,盈利率+0.78% • 💥<a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a> (成本70):开盘拉升","text":"🔥(5.1)美股盘后分析| 赛道为王,持仓全线爆发 📈一、市场反弹核心因素拆解 昨夜美股三大指数集体收涨,道指涨1.62%、标普500涨1.02%、纳指涨0.89%,纳指与标普再创历史新高✨,科技股形成分化,但大部分板块和个股明显反弹,核心驱动因素拆解: 1. 📊财报超预期,AI商业化兑现:谷歌财报爆冷,云AI收入增63%,股价涨近10%;亚马逊云业务增速创四年新高,带动市场情绪。科技股分化源于AI投入与回报的平衡,高变现、低资本压力标的受追捧。 2. 💹宏观面稳定,经济韧性强:美联储维持利率不变(3.50%-3.75%),符合预期;美国一季度GDP增2%,初请失业金人数低位,经济软着陆预期升温。 3. ⛽油价回落,通胀压力缓解:国际油价大跌超2%,消除通胀隐忧,成长股估值修复。 4. 💵月末资金回流,做多情绪集中释放:4月美股月度涨幅创近年最佳,最后交易日资金回流,推动普涨。 🚀二、持仓全线暴涨,浮动盈亏速览 持仓四只标的集体大涨,最弱涨幅超7%,OKLO开盘暴力拉升超11%,完美印证赛道逻辑✅: • 🚀$Rocket Inc.(RKLB)$ (成本70-72):收盘价82.51,涨幅7.13% 浮动盈利:10.51-12.51美元/股,盈利率+14.6%-17.9% • ⚛️$IONQ Inc.(IONQ)$ (成本44.8):收盘价45.15,涨幅7.2% 浮动盈利:0.35美元/股,盈利率+0.78% • 💥$Oklo Inc.(OKLO)$ (成本70):开盘拉升","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/559359589185384","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":559228291270328,"gmtCreate":1777562106239,"gmtModify":1777562319778,"author":{"id":"3483668508098944","authorId":"3483668508098944","name":"我是你的好朋友","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483668508098944","authorIdStr":"3483668508098944"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a> Oklo近期与英伟达及洛斯阿拉莫斯国家实验室达成三方合作,将利用AI数字孪生技术加速核燃料研发与验证,为“核能供电AI工厂”铺路。此外,汇丰银行以买入评级及96美元目标价首次覆盖该公司,Tigress Financial也给予买入评级及130美元目标价。 本人分批买入,目前满仓!","listText":"<a href=\"https://laohu8.com/S/OKLO\">$Oklo Inc.(OKLO)$ </a> Oklo近期与英伟达及洛斯阿拉莫斯国家实验室达成三方合作,将利用AI数字孪生技术加速核燃料研发与验证,为“核能供电AI工厂”铺路。此外,汇丰银行以买入评级及96美元目标价首次覆盖该公司,Tigress Financial也给予买入评级及130美元目标价。 本人分批买入,目前满仓!","text":"$Oklo Inc.(OKLO)$ Oklo近期与英伟达及洛斯阿拉莫斯国家实验室达成三方合作,将利用AI数字孪生技术加速核燃料研发与验证,为“核能供电AI工厂”铺路。此外,汇丰银行以买入评级及96美元目标价首次覆盖该公司,Tigress Financial也给予买入评级及130美元目标价。 本人分批买入,目前满仓!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/559228291270328","isVote":1,"tweetType":1,"viewCount":1235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":484856729575488,"gmtCreate":1759402289561,"gmtModify":1759403656771,"author":{"id":"3483668508098944","authorId":"3483668508098944","name":"我是你的好朋友","avatar":"https://static.tigerbbs.com/5dc815b7a699ae826c85c81bde358c45","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483668508098944","authorIdStr":"3483668508098944"},"themes":[],"title":"","htmlText":"国庆节快乐!我没上车啊","listText":"国庆节快乐!我没上车啊","text":"国庆节快乐!我没上车啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/484856729575488","isVote":1,"tweetType":1,"viewCount":1759,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}